Inhibition of natural killer (NK) cell activity against varicella-zoster virus (VZV)-infected fibroblasts and lymphocyte activation in response to VZV antigen by nitric oxide-releasing agents

Clinical and Experimental Immunology

Volumn 106, Issue 1, 1996, Pages 40-44

  Ito, M ^a   Watanabe, M ^a   Kamiya, H ^b   Sakurai, M ^a  

^a MIE UNIVERSITY   (Japan)

^b MIE NATIONAL HOSPITAL   (Japan)

Author keywords

Natural killer cell; Nitric oxide; Varicella zoster virus

Indexed keywords

3 [ETHYL 2' (HYDROXYIMINO) 5 NITRO 3 HEXENECARBOMOYL]PYRIDINE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NOR 4; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; FIBROBLAST; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VARICELLA ZOSTER VIRUS;

EID: 0029759713     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-807.x     Document Type: Article

References (15)

1. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988; 336:385-8.
2. Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169:1543-55.
3. Granger DL, Hibbs J Jr, Perfect JR et al. Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest 1988; 81:1129-36.
4. Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 1990; 82:772 6.
5. Wright CD, Mulsch A. Busse R et al. Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 1989; 160:813-9.
6. Ito M, Bandyopadhyay S, Matsumoto-Kobayashi M et al. Interleukin 2 enhances natural killing of varicella-zoster virus-infected targets. Cli Exp Immunol 1986; 65:182-9.
7. Ito M, Nakano T, Kamiya T et al. Activation of lymphocytes by varicella-zoster virus (VZV): expression of interleukin-2 receptors on lymphocytes cultured with VZV antigen. J Infect Dis 1992; 165:158 61
8. Kumagai K, Itoh K, Hinuma S et al. Pretreatment of plastic Petri dishes with fetal calf scrum. A simple method for macrophage isolation. J Immunol Methods 1979; 29: 17 25.
9. Zaia JA, Leary PL, Levin ML. Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigen. Infect Immun 1978; 20:646 51.
10. + accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J Exp Med 1986; 164:180 95.
11. Fu Y, Blankenhorn EP. Nitric oxide-induced anti-mitogenic effects in high and low responder rat strains. J Immunol 1992; 148:2217 22.
12. Lepoivre M, Chenais B, Yapo A et al. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J Biol Chem 1990; 265: 14143 9.
13. Devlin J, Palmer RM, Gonde CE et al. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation 1994; 58:592 5.
14. Ochoa JB, Curti B, Peitzman AB et al. Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J Natl Cancer Inst 1992; 84: 864 7.
15. De Maria R, Cifone MG, Trotta R et al. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994; 180:1999 2004.